iHuman
7 hedge funds and large institutions have $6.43M invested in iHuman in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.56% less ownership
Funds ownership: 2.71% → 2.15% (-0.56%)
12% less capital invested
Capital invested by funds: $7.29M → $6.43M (-$861K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$25.4K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$22.9K |
| 3 |
State Street
Boston,
Massachusetts
|
+$4.28K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.14M |
| 2 |
JP Morgan Chase
New York
|
-$316K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$7.69K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.44K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$2.2K |
IH Hedge Fund Activity: Q4 2022 in Review
7 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q4 2022, worth a combined $6.43M — down 12% from $7.29M a quarter earlier.
Fund positioning in IH was balanced in Q4 2022: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $25.4K. The largest seller was Morgan Stanley, cutting an estimated $1.14M.
- 7 institutional investors held iHuman (IH) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $6.43M of iHuman stock for Q4 2022, down 12% quarter-over-quarter.
- 2 funds opened new iHuman positions in Q4 2022 and 2 closed out, a net change of 0 holders.
- The largest iHuman buyer in Q4 2022 was Renaissance Technologies, an estimated $25.4K added.
- The largest iHuman seller in Q4 2022 was Morgan Stanley, an estimated $1.14M sold.
Based on aggregated 13F filings for Q4 2022.